Today’s Solutions: December 20, 2025

Women receive only a slim 2 percent of venture capital funds, but Anthemis and Barclays’, Female Innovator Lab, is looking to change this statistic. The New York-based group is looking to back female financial technology startups to level the playing field for female entrepreneurs. 

The group assesses each startup’s needs and works as not just a backer, but a partner and support system as well. Anthemis cofounder, Amy Nauiokas, says many women leave the financial industry, not because of family commitments or lack of talent, but because opportunities for mobility in the industry are limited. For many women, the support is just not the same as for their male counterparts. 

Managing over $380 million in assets, Anthemis is well equipped to handle challenges specific to the industry and thinks traditionally underfunded groups are the key to new innovation in the field of financial technology. Nauiokas says, “As far as I’m concerned, we need to make sure that every company we help create, every company we fund, and every business we build becomes in itself a kind of petri dish for diversity and inclusion.”

Solutions News Source Print this article
More of Today's Solutions

Try this simple breathing exercise to rid yourself of cold hands and feet

Do you often find that your hands and feet are colder than the rest of your body? This can be perplexing, especially when gloves ...

Read More

Roman jars reveal the secrets of ancient winemaking

Archaeologists are still putting the full story of human history together. From the discovery of a Viking shipyard in Sweden to the Sistine Chapel ...

Read More

Cancer detection breakthrough revealed via butterfly-inspired imaging

In the world of sensory perception, other creatures frequently outperform humans. A research team has created an imaging sensor that looks into the elusive ultraviolet ...

Read More

Advancements in vision restoration: CRISPR gives hope to patients 

In a revolutionary development, CRISPR gene editing emerged as a beacon of hope for people suffering from genetic blindness. The results of a Phase ...

Read More